BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14279688)

  • 1. [OBSERVATIONS AND RESULTS OF TREATMENT WITH CYCLOPHOSPHAMIDE IN 45 CASES OF LUNG CANCER].
    GRASSI F; SCOCCIA S; TANSINI G
    G Ital Chemioter; 1964; 11():135-43. PubMed ID: 14279688
    [No Abstract]   [Full Text] [Related]  

  • 2. [91 CASES OF CONTINUOUS SIMULTANEOUS POLYCHEMOTHERAPY IN INOPERABLE LUNG CANCERS].
    ISRAEL ; SORSC L; REBOUL R
    Presse Med (1893); 1965 Mar; 73():701-4. PubMed ID: 14252397
    [No Abstract]   [Full Text] [Related]  

  • 3. [1ST OTORHINOLARYNGOLOGICAL EXPERIENCES WITH ENDOXAN "ATTACK THERAPY"].
    HAAS E
    Z Laryngol Rhinol Otol; 1964 Sep; 43():551-8. PubMed ID: 14335063
    [No Abstract]   [Full Text] [Related]  

  • 4. [OBSERVATIONS ON THE TREATMENT OF LUNG CANCER WITH ENDOXAN].
    ZSCHAEGE B; DAHM K
    Med Welt; 1964 Mar; 11():550-62. PubMed ID: 14188955
    [No Abstract]   [Full Text] [Related]  

  • 5. THIOTEPA AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF ADVANCED MAMMARY CANCER.
    GORDON I; MCARTHUR J
    Scott Med J; 1965 Jan; 10():27-33. PubMed ID: 14262959
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of recurrent breast cancer with lung metastasis and overexpression of HER2 that responded to UFT and cyclophosphamide combination therapy after sequential treatments with epirubicin, taxanes, and trastuzumab].
    Nishimura R; Nagao K; Miyayama H; Okazaki S; Nakagawa K; Fujimura Y
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):879-82. PubMed ID: 12852361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [REMISSION OBTAINED BY CYCLOPHOSPHAMIDE IN 2 CASES OF PLEURO-PULMONARY SECONDARY NEOPLASMS].
    CHARPIN J
    Mars Med; 1963; 100():1181-3. PubMed ID: 14106597
    [No Abstract]   [Full Text] [Related]  

  • 8. [SOME CURRENT PROBLEMS OF TUMOR THERAPY WITH CYCLOPHOSPHAMIDE].
    BROCK N
    Anglo Ger Med Rev; 1964 Sep; 2():460-77. PubMed ID: 14277219
    [No Abstract]   [Full Text] [Related]  

  • 9. Trial of heparin and cyclophosphamide (NSC-26271) in the treatment of lung cancer.
    Edlis HE; Goudsmit A; Brindley C; Niemetz J
    Cancer Treat Rep; 1976 May; 60(5):575-8. PubMed ID: 991145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide vs cyclophosphamide in cancer therapy.
    Weiss RB
    Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE TREATMENT OF ADVANCED CANCER WITH A COMBINATION OF 5-FLUOROURACIL, CYTOXAN, AND METHOTREXATE.
    GRADY ED
    J Med Assoc Ga; 1964 Sep; 53():285-90. PubMed ID: 14246542
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended administration of oral etoposide and oral cyclophosphamide for the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
    Grunberg SM; Crowley J; Livingston R; Gill I; Williamson SK; O'Rourke T; Braun T; Marshall ME; Weick JK; Balcerzak SP
    J Clin Oncol; 1993 Aug; 11(8):1598-601. PubMed ID: 8393099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemetrexed and cyclophosphamide combination therapy for the treatment of non-small cell lung cancer.
    Li D; He S
    Int J Clin Exp Pathol; 2015; 8(11):14693-700. PubMed ID: 26823793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line oral chemotherapy (lomustine, cyclophosphamide, etoposide) versus intravenous therapy (cyclophosphamide, doxorubicin, and vincristine) in patients with relapsed small cell lung cancer: a randomized phase II study of GFPC 0501.
    Gervais R; Le Caer H; Monnet I; Falchero L; Baize N; Olivero G; Thomas P; Berard H; Auliac JB; Chouaid C;
    Clin Lung Cancer; 2015 Mar; 16(2):100-5. PubMed ID: 25467927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cyclophosphamide activity in patients treated for small cell carcinoma of the lung.
    Sarpel SC; Lad T; Epstein RB
    J Clin Oncol; 1983 Jan; 1(1):29-32. PubMed ID: 6321670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CYCLOPHOSPHAMIDE IN THE TREATMENT OF TUMORS OF THE HEAD AND NECK. CONTRIBUTION TO ITS STUDY OF CONTINUOUS ARTERIAL INFUSSION].
    CAPPELLANO R
    Rev Bras Cir; 1964 Nov; 48():375-89. PubMed ID: 14260731
    [No Abstract]   [Full Text] [Related]  

  • 17. [CASE OF AN UNDIFFERENTIATED TYPE OF PRIMARY HEPATIC CANCER].
    FURUKAWA I; OHASHI M; AOKI A; TAKAHASHI T
    Naika; 1964 Sep; 14():765-8. PubMed ID: 14202928
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug induced pulmonary disease. Diffuse interstitial pneumonitis during chemoradiotherapy for small cell carcinoma of the lung. Two cases (author's transl)].
    Riou R; Duvillard P; Touraine R
    Poumon Coeur; 1982; 38(1):57-62. PubMed ID: 6283505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ON THE TOLERANCE TO HIGH SINGLE DOSES OF ENDOXON IN THE TREATMENT OF METASTASIZING CANCER].
    KAUFMANN EF
    Z Gesamte Inn Med; 1965 Feb; 20():91-3. PubMed ID: 14270007
    [No Abstract]   [Full Text] [Related]  

  • 20. [TREATMENT OF MALIGNANT TUMORS BY CYCLOPHOSPHAMIDE].
    POMMATAU E; DARGENT M; REVILLARD JP; VAUZELLE-USCLARD C; GIGNOUX M
    Sem Hop; 1964 Feb; 40():452-62. PubMed ID: 14139193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.